Human Insulin Degrading Enzyme (IDE) ELISA Kit (Part hIDE-Biotin) kw: insulin degrading enzyme, insulysin
Human Insulin Degrading Enzyme (IDE) ELISA Kit
Dynamic Assay Range: 600 pg/ml - 180 ng/ml. Sensitivity: 544 pg/ml. 96T
Lead Time: Approximately 1.5 weeks
Specifications
Methods Overview:
The included ELISA micro-strip plate is provided pre-coated with an a monoclonal capture antibody selective to the antigen. Samples are mixed by the experimenter with a provided biotin-linked detection antibody and a streptavidin-HRP solution, and then the mixture is added to the plate for 60 min at 37oC. The plate is washed after the 60 min incubation period and color reagents are added, resulting in a reaction that yields a blue colored solution. A stop solution is applied to terminate the reaction, and the resulting yellow solution is measured at 450nm.
Protocol Sandwich ELISA Methods to Insulin Degrading Enzyme (IDE)
ELISA Assay Steps
Introduction to Insulin Degrading Enzyme:
Insulin-degrading enzyme (IDE) is a zinc-binding protease known to cleave short polypeptides with variable sequences. IDE was first identifiable for its ability to degrade the B chain of insulin and has since been shown to have additional substrates, including the signaling peptides glucagon, TGF alpha, β-endorphin and amyloid-beta (Aβ). In vitro and in vivo studies have shown correlations between IDE activity levels, Aβ degradation, and Alzheimer’s disease. Mice engineered to lack both alleles of the IDE gene show a 50% decrease in Aβ degradation, resulting in cerebral accumulation of Aβ. Studies of genetically inherited forms of Alzheimer’s show reduction in both IDE expression and catalytic activity among affected individuals.
Gerneral References on Insulin Degrading Enzyme
For research only. Not for diagnostics.
Safety: Stop solution contains acid. Avoid ingestion, skin and eye contact.
Storage: 4°C. 6 months.
|